ResMed Inc.RMDNYSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+2.6%
5Y CAGR+7.4%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+2.6%/yr
Quarterly compound
5Y CAGR
+7.4%/yr
Recent deceleration
Percentile
P82
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.78% |
| Q3 2025 | 0.09% |
| Q2 2025 | 7.00% |
| Q1 2025 | 2.01% |
| Q4 2024 | 4.75% |
| Q3 2024 | 1.84% |
| Q2 2024 | 3.33% |
| Q1 2024 | 1.82% |
| Q4 2023 | 11.56% |
| Q3 2023 | -2.81% |
| Q2 2023 | -0.06% |
| Q1 2023 | 6.56% |
| Q4 2022 | 7.19% |
| Q3 2022 | 3.50% |
| Q2 2022 | 6.37% |
| Q1 2022 | -2.60% |
| Q4 2021 | -0.39% |
| Q3 2021 | 3.18% |
| Q2 2021 | 9.71% |
| Q1 2021 | -3.29% |
| Q4 2020 | 5.43% |
| Q3 2020 | -2.38% |
| Q2 2020 | -0.06% |
| Q1 2020 | 5.28% |
| Q4 2019 | 5.45% |
| Q3 2019 | -3.06% |
| Q2 2019 | 6.62% |
| Q1 2019 | 2.13% |
| Q4 2018 | 11.84% |
| Q3 2018 | -5.35% |
| Q2 2018 | 5.28% |
| Q1 2018 | -1.57% |
| Q4 2017 | 14.46% |
| Q3 2017 | -5.61% |
| Q2 2017 | 8.03% |
| Q1 2017 | -3.03% |
| Q4 2016 | 14.82% |
| Q3 2016 | -10.72% |
| Q2 2016 | 16.01% |
| Q1 2016 | -2.49% |